ncRNA name
hsa-miR-876-3p
Specific or universal ncRNAs
Specific ncRNAs
Class
MicroRNA
Biomarker
No
Biomarker application
Upstream regulatory factors
Not available
Downstream target
TMED3
Cancer name
Gastric Cancer
Cancer site
Stomach
Treatment type
Chemotherapy
Drug
Cisplatin
Impact of wild-type ncRNA on chemotherapy resistance
Up
Impact of knockdown of ncRNA on chemotherapy resistance
Impact of overexpression of ncRNA on chemotherapy resistance
ncRNA differential expression in
cancer
patients vs. healthy people
Not available
Number of patients
Not available
Male patients
Not available
Female patients
Not available
Age range and number
Not available
PMID
Description
MiR-876-3p enhanced cisplatin sensitivity and restricted stem cell-like features of GC through targeting TMED3.
Tissue resource
gastric cancer tissues and corresponding normal tissues
gastric cancer cell lines MGC-803
gastric cancer cell lines AGS
gastric cancer cell lines BGC-823
gastric cancer cell lines SGC-7901
gastric cancer cell lines MKN-45
gastric cancer cell lines N87
gastric cancer cell lines HGC-27
normal cell lines GES-1
Experiment
PCR,Western blot,Luciferase reporter assay
Institute
the First Affiliated Hospital of Anhui Medical University
American Type Culture Collection
Country
China
USA
Continent
Asia
North American